Prevention of pre-eclampsia: Status and perspectives 2000

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 94, Issue 1, 2001, Pages 13-22

  Wallenburg, Henk C S ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Calcium supplementation; Low dose aspirin; Pre eclampsia; Pregnancy induced hypertensive disorders; Prevention; Vitamin C and E supplementation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; CALCIUM; DIURETIC AGENT; LINOLEIC ACID; MAGNESIUM; PLACEBO;

FETUS MORTALITY; HUMAN; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; NEWBORN MORBIDITY; PATIENT COMPLIANCE; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; VITAMIN SUPPLEMENTATION;

EID: 0035188632     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00303-1     Document Type: Review

References (87)

1. Detecting hypertensive disorders of pregnancy
2. The classification and definition of the hypertensive disorders of pregnancy
3. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean
4. Pregnancy-induced hypertensive disorders
5. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies
6. Prediction and prevention of pregnancy-induced hypertensive disorders
7. Pre-eclampsia: An excessive inflammatory response to pregnancy
8. Treatment of eclampsia
9. National high blood pressure education program working group report on high blood pressure in pregnancy
10. A randomized controlled trial of bed rest and sedation or normal activity and non-sedation in the management of non-albuminuric hypertension in late pregnancy
11. The relation between life stress and hypertensive complications during pregnancy
12. Dietary sodium restriction during pregnancy: A historical review
13. (Patho)physiological implications of chronic dietary sodium restriction during pregnancy: A longitudinal prospective randomized study
14. Sodium-blood pressure interrelationships in pregnancy
15. Dietary sodium restriction does not prevent gestational hypertension: A dutch two-center randomized trial
16. Low sodium diet and pregnancy-induced hypertension: A multi-centre randomised controlled trial
17. Low-sodium diet in pregnancy: Effects on blood pressure and maternal nutritional status
18. Central hemodynamic observations in untreated preeclamptic patients
19. Dietary sodium restriction in the prophylaxis of hypertensive disorders of pregnancy: Effects on the intake of other nutrients
20. Balanced protein/energy supplementation in pregnancy
21. Isocaloric balanced protein supplementation in pregnancy
22. Energy, protein restriction in pregnant women with high weight-for-height or weight gain
23. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial
24. On the role of magnesium in fetal hypotrophy, pregnancy-induced hypertension, and pre-eclampsia
25. Magnesium supplementation in pregnancy. A double-blind study
26. Magnesium supplementation during pregnancy: A double-blind randomized controlled clinical trial
27. The implications of hypozincemia in pregnancy
28. Zinc supplementation during pregnancy: A double-blind randomized controlled trial
29. Zinc supplementation during pregnancy: A double blind randomised controlled trial
30. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia
31. Trial of calcium to prevent preeclampsia
32. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, pre-eclampsia and preterm birth: An Australian randomized trial
33. Oxidative stress and altered endothelial cell function in preeclampsia
34. Partners in defense: Vitamin E and vitamin C
35. Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia
36. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomised trial
37. Principles and applications of manipulation of prostaglandin synthesis in pregnancy
38. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia; indications from a 50-year-old trial
39. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy
40. The effect of 3 g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy-induced hypertension
41. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration
42. Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia
43. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic+docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia
44. Pharmacological prevention and treatment of hypertensive disorders in pregnancy
45. Diuretics for prevention of pre-eclampsia
46. Treatment of hypertension in pregnant women
47. The role of calcium channel blockers in the treatment of women with pre-eclampsia
48. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia
49. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors
50. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
51. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease
52. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae
53. Aspirin as an antiplatelet drug
54. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells
55. Aspirin in pregnancy
56. The use of low dose aspirin in pregnancy
57. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials
58. The pharmacological prevention of pre-eclampsia
59. Low-dose aspirin in obstetrics
60. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease
61. Antiplatelet agents for IUGR and pre-eclampsia
62. A meta-analysis of low-dose aspirin for the prevention of intrauterine growth retardation
63. Low-dose aspirin in hypertensive pregnant women: Effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn
64. Prevention of preeclampsia with low-dose aspirin in healthy nulliparous pregnant women
65. Low-dose aspirin therapy to prevent preeclampsia
66. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women
67. Where next for prophylaxis against pre-eclampsia?
68. ECPPA: Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women
69. Low-dose aspirin to prevent preeclampsia in women at high risk
70. Barbados low dose aspirin study in pregnancy (BLASP): A randomised trial for the prevention of pre-eclampsia and its complications
71. A randomised trial of low dose aspirin for primiparae in pregnancy
72. Low-dose aspirin in nulliparous women: Safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications
73. Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality
74. Low-dose aspirin in pregnancy and early childhood development: Follow-up of the collaborative low-dose aspirin study in pregnancy
75. Low-dose aspirin in obstetrics
76. Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required
77. Ambulatory blood pressure monitoring in pregnancy
78. Proteinuria and its assessment in normal and hypertensive pregnancy
79. Maternal perfusion with low-dose aspirin preferentially inhibits placental thromboxane while sparing prostacyclin
80. Prophylactic aspirin treatment: The merits of timing
81. Time-dependent changes in the pharmacokinetics of aspirin
82. Administration time-dependent effects of aspirin in women at differing risk for preeclampsia
83. Are pill counts valid measures of compliance in clinical obstetric trials?
84. Underestimation of the true benefits of antihypertensive treatment: An assessment of some important sources of error
85. 2 B reduction versus pregnancy outcome in a low-dose aspirin trial
86. Low-dose aspirin in high-risk pregnancy?